Phaseline

Targets › GABRB3

GABRB3 (Gamma-aminobutyric acid receptor subunit beta-3): drug programs, companies and trials

36 programs from 34 companies in 65 trials: 32 Phase 4, 13 Phase 3, 12 Phase 2, 8 Phase 1; Other, Psychiatry, Neurology; next expected readout Nov 2026.

Beta subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain. GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s). (UniProt, P28472)

Open in Phaseline: the race on GABRB3, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
Rush University Medical CenterMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Minor Surgical Procedures With Monitored Anesthesia CareNov 2026
Kaohsiung Medical University Chung-Ho Memorial HospitalPropofol
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Lung Cancer; Hepatocellular Carcinoma; Ovarian CancerNov 2026
University of Sao PauloEszopiclone
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4InsomniaDec 2026
Medical University of South CarolinaRemimazolam besylate
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Burn ScarJan 2027
Medical University of South CarolinaMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Anesthesia InductionApr 2027
Seoul National University HospitalRemimazolam Besylate
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Remimazolam; Aortic Aneurysm, ThoracoabdominalApr 2027
SK Life ScienceCenobamate (YKP3089)
GABA-A receptor; anion channel positive allosteric modulator; Sodium channel alpha subunit inhibitor
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Focal Onset Seizure; Partial EpilepsyMay 2027
Clinical Hospital Centre ZagrebRemimazolam besylate
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Colonic PolypNov 2027
Laureate Institute for Brain Research, Inc.Lorazepam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Depression, AnxietyDec 2027
David LyubashevskyMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Transcatheter Aortic Valve Replacement (TAVR)Apr 2028
VA Office of Research and DevelopmentLorazepam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Stress Disorders, Post-TraumaticJun 2029
Haisco Pharmaceutical GroupCipepofol (HSK3486)
GABA-A receptor; anion channel agonist
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Anesthesia; Myocardial Injury–
University of OklahomaMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Laceration of Skin–
Universidade Federal de GoiasMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Child Behavior–
Beijing Shijitan Hospital, Capital Medical UniversityRemimazolam Besylate
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Effect of Drug–
Xi'an Aerospace General HospitalRemimazolam besylate
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 4Cholelithiasis–
University of California, Los AngelesCBD 20 mg
GABA-A receptor; anion channel positive allosteric modulator
HTR1A, GABRA1, GABRB2, GABRG2, GABRB3, GABRA4, SLC1A2, SLC1A3Phase 3Spinocerebellar Ataxias; Non-healing Wound; Sleep Apnea, Obstructive; Cervical Spinal Cord Injury …Dec 2026
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3Laceration of SkinDec 2026
University of Texas Southwestern Medical CenterPropofol
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3AnesthesiaJan 2027
Ono PharmaceuticalCenobamate
GABA-A receptor; anion channel positive allosteric modulator; Sodium channel alpha subunit inhibitor
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3Partial Epilepsy; Epilepsies, PartialJan 2027
Southeast University, ChinaRemimazolam besylate
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3Remimazolam BesylateJan 2027
UCB Biopharma SRLAlprazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3Stereotypical Prolonged Seizures; Ophthalmology; Opioid Abuse; Drug InteractionsMar 2027
LipocineBrexanolone
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3Depression, Postpartum; Alzheimer Dementia; PTSDAug 2027
University Hospital, MontpellierMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3AnesthesiaOct 2027
Yale UniversityEszopiclone
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3Sleep ApneaJan 2030
Stanford UniversityMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3Seizures–
Romanian Society for Enteral and Parenteral NutritionRemimazolam Besylate
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 3Postoperative Cognitive Dysfunction–
Flinders UniversityEszopiclone
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 2OSA - Obstructive Sleep ApneaMay 2027
Acacia PharmaRemimazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 2Pediatric ALL; Benzodiazepines; Cataract Surgery; Sedation for Diagnostic Gastroscopy …Oct 2027
University of California, Los AngelesEszopiclone
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 2Obstructive Sleep ApneaAug 2028
M.D. Anderson Cancer CenterLorazepam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 2DeliriumDec 2028
Insel Gruppe AG, University Hospital BernMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 2Anxiety–
University Hospital, Grenoblemidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 2Neurocognitive Disorders–
CAMC Health SystemMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 1AnesthesiaApr 2027
Qianfoshan HospitalRemimazolam Besylate
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 1Chronic Kidney DiseasesJun 2027
Makassed General HospitalMidazolam
GABA-A receptor; anion channel positive allosteric modulator
GABRA1, GABRB2, GABRG2, GABRB3, GABRA4Phase 1Healthy Female Volunteer–

Conditions

Anesthesia (6) Partial Epilepsy (2) Anxiety (2) Laceration of Skin (2) Epilepsies, Partial (1) Neurocognitive Disorders (1) Remimazolam Besylate (1) Obstructive Sleep Apnea (1) Remimazolam (1) Aortic Aneurysm, Thoracoabdominal (1) Depression, Postpartum (1) Alzheimer Dementia (1)

Modalities

small molecule (35)

Companies

University of California, Los Angeles (2) Medical University of South Carolina (2) Ono Pharmaceutical (1) University Hospital, Grenoble (1) Southeast University, China (1) Seoul National University Hospital (1) Lipocine (1) Yale University (1) Kaohsiung Medical University Chung-Ho Memorial Hospital (1) Stanford University (1) Xi'an Aerospace General Hospital (1) Insel Gruppe AG, University Hospital Bern (1) David Lyubashevsky (1) UCB Biopharma SRL (1) Haisco Pharmaceutical Group (1) Clinical Hospital Centre Zagreb (1) University of Texas Southwestern Medical Center (1) University of Oklahoma (1) VA Office of Research and Development (1) Rush University Medical Center (1)

Related targets

GABRA1 (36) GABRB2 (36) GABRG2 (36) GABRA4 (36) HTR1A (1) SLC1A2 (1) SLC1A3 (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.